Tacrolimus ointment was approved in December 2000 and is marketed as Protopic by Fujisawa Healthcare, Inc. (Deerfield, IL). It is available in two strengths; the 0.03% ointment is approved for ...

March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...

Perrigo announced the availability of Tacrolimus Ointment, the generic version of Astellas’ Protopic Ointment. Protopic is an immunomodulator that is indicated as second-line therapy for short-term ...

Glenmark Pharmaceuticals Limited, a research‐led, integrated, global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) Tacrolimus Ointment, ...

Glenmark Pharmaceuticals Ltd on Thursday said it has received approval from the US health regulator for its generic Tacrolimus ointment indicated for the treatment of moderate to severe atopic ...

Glenmark has received permission from the Food and Drug Administration for Tacrolimus Ointment, 0.03%, the generic of Leo Pharma's Protopic. Protopic Ointment, both 0.03% and 0.1% for adults, and only ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated global pharmaceutical company, has received the final United States Food & Drug Administration (USFDA) approval for Tacrolimus ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In 2006, when the FDA instilled black box warnings on ...

Glenmark Pharma reported a profit after tax of Rs 173.10 crore for the June quarter. Glenmark’s reported a 22.5 per cent YoY rise in consolidated revenue at Rs 3,401.60 crore. Glenmark’s Ebitda stood ...

Please provide your email address to receive an email when new articles are posted on . Tacrolimus may be a safe and effective treatment option for atopic blepharoconjunctivitis, a small study ...

Glenmark's Tacrolimus ointment, 0.03 per cent, will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, it added. The Protopic Ointment, 0.03 per cent market (brand and all available ...